{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:47:58Z","timestamp":1782287278381,"version":"3.54.5"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by recurrent eczematous lesions and intense pruritus. The aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, plays a pivotal role in epidermal barrier differentiation, immune regulation, environmental responses, and microbiota\u2013metabolite interactions, and has emerged as a potential therapeutic target with the clinical development of AHR agonists. However, a systematic bibliometric overview of the knowledge structure and evolving trends in this field is still lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>After screening, deduplication, and standardization, English-language publications on AD and AHR published between 2005 and 2025 were retrieved from the Web of Science Core Collection (WoSCC) and Scopus. VOSviewer, CiteSpace, and Scimago Graphica were then used to visualize publication trends, collaboration networks, journal distribution, co-cited references, and keyword evolution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 306 publications were included, comprising 168 original articles and 138 reviews. Research on AHR in AD began in 2005 and entered a phase of rapid growth after 2020. The studies involved 49 countries\/regions, with the United States leading in both publication output and international collaboration, followed by Japan, China, South Korea, and Germany as major contributors. Journal and co-citation analyses indicated that this field is characterized by the intersection of dermatology and basic immunology. Keyword clustering highlighted four major themes: immune and inflammatory regulation, skin barrier function and environmental exposure, the microbiota\u2013metabolism\u2013comorbidity axis, and AHR-targeted therapy and clinical evaluation. Overall, the research focus has gradually expanded from basic mechanisms to microbiota-targeted regulation and clinical translation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study systematically mapped the research landscape and developmental trends of AHR in AD over the past two decades, revealing a clear shift from investigations centered on its role as a classical environmental sensor to multidimensional mechanistic studies involving immune regulation, skin barrier function, and the interplay among the microbiota, metabolism, and comorbidities. These findings provide clinicians and researchers with a rapid overview of the academic frontiers in this field and offer a useful reference for the development of AHR-targeted therapeutic strategies and the identification of future research directions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1840065","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:07:06Z","timestamp":1782284826000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Global research trends on the aryl hydrocarbon receptor in atopic dermatitis: a bibliometric and visualized analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhiquan","family":"Li","sequence":"first","affiliation":[{"name":"Clinical Medical College, Jiangxi University of Chinese Medicine, Nanchang","place":["Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenwei","family":"Deng","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Jiangxi University of Chinese Medicine, Nanchang","place":["Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foling","family":"Chen","sequence":"additional","affiliation":[{"name":"Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyuan","family":"Cao","sequence":"additional","affiliation":[{"name":"Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwen","family":"Fan","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Jiangxi University of Chinese Medicine, Nanchang","place":["Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Song","sequence":"additional","affiliation":[{"name":"Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(24)02519-4","article-title":"Atopic dermatitis.","volume":"405","author":"Guttman-Yassky","year":"2025","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s13555-022-00819-6","article-title":"Burden of atopic dermatitis in adults and adolescents: a systematic literature review.","volume":"12","author":"Fasseeh","year":"2022","journal-title":"Dermatol Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jaci.2024.04.029","article-title":"Exploring the skin microbiome in atopic dermatitis pathogenesis and disease modification.","volume":"154","author":"H\u00fclp\u00fcsch","year":"2024","journal-title":"J Allergy Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jid.2024.01.011","article-title":"Adding fuel to the fire? The skin microbiome in atopic dermatitis.","volume":"144","author":"Saheb Kashaf","year":"2024","journal-title":"J Invest Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2147\/JAA.S293900","article-title":"Genetic\/environmental contributions and immune dysregulation in children with atopic dermatitis.","volume":"15","author":"Chong","year":"2022","journal-title":"J Asthma Allergy."},{"key":"B6","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2340\/00015555-3003","article-title":"Antioxidative phytochemicals accelerate epidermal terminal differentiation via the AHR-OVOL1 pathway: implications for atopic dermatitis.","volume":"98","author":"Furue","year":"2018","journal-title":"Acta Derm Venereol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/toxsci\/kfm096","article-title":"An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann lecture, international congress of toxicology-XI.","volume":"98","author":"Okey","year":"2007","journal-title":"Toxicol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.3390\/ijms20215424","article-title":"Aryl hydrocarbon receptor in atopic dermatitis and psoriasis.","volume":"20","author":"Furue","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/ni.3614","article-title":"The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin.","volume":"18","author":"Hidaka","year":"2017","journal-title":"Nat Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.jaci.2018.11.036","article-title":"A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor.","volume":"143","author":"Yu","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2023.12.013","article-title":"Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: a clinical review.","volume":"154","author":"Silverberg","year":"2024","journal-title":"J Allergy Clin Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jaad.2024.05.023","article-title":"Tapinarof cream 1% once daily: significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials.","volume":"91","author":"Silverberg","year":"2024","journal-title":"J Am Acad Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/S40037-021-00695-4","article-title":"Bibliometrics: methods for studying academic publishing.","volume":"11","author":"Ninkov","year":"2022","journal-title":"Perspect Med Educ."},{"key":"B14","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1172\/JCI65642","article-title":"Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis.","volume":"123","author":"van den Bogaard","year":"2013","journal-title":"J Clin Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2014.04.019","article-title":"Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions.","volume":"40","author":"Di Meglio","year":"2014","journal-title":"Immunity."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans.","volume":"137","author":"Smith","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.3390\/cells10113176","article-title":"Role of AHR ligands in skin homeostasis and cutaneous inflammation.","volume":"10","author":"Fern\u00e1ndez-Gallego","year":"2021","journal-title":"Cells."},{"key":"B18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jdermsci.2015.07.011","article-title":"Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor.","volume":"80","author":"Furue","year":"2015","journal-title":"J Dermatol Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/1346-8138.12717","article-title":"Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor.","volume":"42","author":"Takei","year":"2015","journal-title":"J Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2931","DOI":"10.1038\/cddis.2017.322","article-title":"Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis.","volume":"8","author":"Tsuji","year":"2017","journal-title":"Cell Death Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jid.2016.06.627","article-title":"Aryl hydrocarbon receptor in keratinocytes is essential for murine skin barrier integrity.","volume":"136","author":"Haas","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.3390\/ijms21155382","article-title":"Regulation of filaggrin, loricrin, and involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: pathogenic implications in atopic dermatitis.","volume":"21","author":"Furue","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaad.2018.06.047","article-title":"A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis.","volume":"80","author":"Peppers","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jaad.2020.05.135","article-title":"Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis.","volume":"84","author":"Paller","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/CM9.0000000000000591","article-title":"Aryl hydrocarbon receptor expression in serum, peripheral blood mononuclear cells, and skin lesions of patients with atopic dermatitis and its correlation with disease severity.","volume":"133","author":"Hu","year":"2020","journal-title":"Chin Med J (Engl)."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.2147\/CCID.S430915","article-title":"Unbalanced aryl hydrocarbon receptor expression in peripheral and lesional T cell subsets of atopic dermatitis.","volume":"16","author":"Hu","year":"2023","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5021\/ad.2020.32.5.360","article-title":"2,3,7,8-tetrachlorodibenzo- p-dioxin regulates the expression of aryl hydrocarbon receptor-related factors and cytokines in peripheral blood mononuclear cells and CD4+ T cells from patients with atopic dermatitis and psoriasis.","volume":"32","author":"Um","year":"2020","journal-title":"Ann Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.jid.2018.11.012","article-title":"Activation of aryl hydrocarbon receptor negatively regulates thymic stromal lymphopoietin gene expression via protein kinase c\u03b4-p300\u2013NF-\u03baB pathway in keratinocytes under inflammatory conditions.","volume":"139","author":"Jeong","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/jcm9030891","article-title":"Aryl hydrocarbon receptor activation downregulates IL-33 expression in keratinocytes via ovo-like 1.","volume":"9","author":"Tsuji","year":"2020","journal-title":"J Clin Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jaci.2025.05.007","article-title":"Dissecting key contributions of TH2 and TH17 cytokines to atopic dermatitis pathophysiology.","volume":"156","author":"Meesters","year":"2025","journal-title":"J Allergy Clin Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"27995","DOI":"10.1038\/srep27995","article-title":"Urban particulate matter down-regulates filaggrin via COX2 expression\/PGE2 production leading to skin barrier dysfunction.","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e145185","DOI":"10.1172\/jci.insight.145185","article-title":"Particulate matter causes skin barrier dysfunction.","volume":"6","author":"Kim","year":"2021","journal-title":"JCI Insight."},{"key":"B33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/exd.14724","article-title":"Particulate matter 2.5 induces the skin barrier dysfunction and cutaneous inflammation via AhR- and T helper 17 cell-related genes in human skin tissue as identified via transcriptome analysis.","volume":"32","author":"Kim","year":"2023","journal-title":"Exp Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jid.2023.07.027","article-title":"Benvitimod inhibits IL-4\u2013 and IL-13\u2013induced tight junction impairment by activating AHR\/ARNT pathway and inhibiting STAT6 phosphorylation in human keratinocytes.","volume":"144","author":"Wang","year":"2024","journal-title":"J Invest Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41423-025-01264-z","article-title":"The AhR-Ovol1-Id1 regulatory axis in keratinocytes promotes epidermal and immune homeostasis in atopic dermatitis-like skin inflammation.","volume":"22","author":"Chen","year":"2025","journal-title":"Cell Mol Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1300378","DOI":"10.3389\/fimmu.2023.1300378","article-title":"Tryptophan, an important link in regulating the complex network of skin immunology response in atopic dermatitis.","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/ijms26041618","article-title":"The aryl hydrocarbon receptor (AHR): peacekeeper of the skin.","volume":"26","author":"Dawe","year":"2025","journal-title":"Int J Mol Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2044723","DOI":"10.1080\/19490976.2022.2044723","article-title":"Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis.","volume":"14","author":"Fang","year":"2022","journal-title":"Gut Microbes."},{"key":"B39","doi-asserted-by":"publisher","first-page":"7735","DOI":"10.3390\/ijms23147735","article-title":"Limosilactobacillus reuteri attenuates atopic dermatitis via changes in gut bacteria and indole derivatives from tryptophan metabolism.","volume":"23","author":"Fang","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1111\/all.16644","article-title":"Phytic acid improves the skin barrier function in murine models of atopic dermatitis through skin microbiota-derived indole-i-propionic acid.","volume":"80","author":"Wang","year":"2025","journal-title":"Allergy."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/all.15640","article-title":"Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction.","volume":"78","author":"Kim","year":"2023","journal-title":"Allergy."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chom.2021.05.011","article-title":"Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor.","volume":"29","author":"Uberoi","year":"2021","journal-title":"Cell Host Microbe."},{"key":"B43","doi-asserted-by":"publisher","first-page":"106483","DOI":"10.1016\/j.isci.2023.106483","article-title":"Gram-positive anaerobic cocci guard skin homeostasis by regulating host-defense mechanisms.","volume":"26","author":"van der Krieken","year":"2023","journal-title":"iScience."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1726557","DOI":"10.3389\/fimmu.2025.1726557","article-title":"Commensal Staphylococci attenuate Staphylococcus aureus skin colonization and inflammation via AHR-dependent signaling.","volume":"16","author":"Riebelmann","year":"2025","journal-title":"Front Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/intimm\/dxae053","article-title":"The role of the skin in the atopic march.","volume":"36","author":"Tang","year":"2024","journal-title":"Int Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2430420","DOI":"10.1080\/19490976.2024.2430420","article-title":"Unraveling the gut-skin axis in atopic dermatitis: exploiting insights for therapeutic strategies.","volume":"16","author":"Rios-Carlos","year":"2024","journal-title":"Gut Microbes."},{"key":"B47","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/all.13660","article-title":"High levels of butyrate and propionate in early life are associated with protection against atopy.","volume":"74","author":"Roduit","year":"2019","journal-title":"Allergy."},{"key":"B48","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jaad.2025.05.1391","article-title":"Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitis.","volume":"93","author":"Bissonnette","year":"2025","journal-title":"J Am Acad Dermatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"745e1","DOI":"10.1016\/j.jaad.2025.05.1386","article-title":"Focused update: guidelines of care for the management of atopic dermatitis in adults.","volume":"93","author":"Davis","year":"2025","journal-title":"J Am Acad Dermatol."},{"key":"B50","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/all.16009","article-title":"Treatment of atopic dermatitis: recently approved drugs and advanced clinical development programs.","volume":"79","author":"M\u00fcller","year":"2024","journal-title":"Allergy."},{"key":"B51","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/cimb47080659","article-title":"Targeting intracellular pathways in atopic dermatitis with small molecule therapeutics.","volume":"47","author":"Nitulescu","year":"2025","journal-title":"Curr Issues Mol Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/cea.70136","article-title":"New topical and systemic treatments for atopic dermatitis.","volume":"55","author":"Mirali","year":"2025","journal-title":"Clin Exp Allergy: J Br Soc Allergy Clin Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2473524","DOI":"10.1080\/19490976.2025.2473524","article-title":"The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential.","volume":"17","author":"Jimenez-Sanchez","year":"2025","journal-title":"Gut Microbes."},{"key":"B54","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/ced\/llae502","article-title":"Itching for innovation: the role of aryl hydrocarbon receptor agonists as a future therapy for atopic dermatitis.","volume":"50","author":"Wazir","year":"2025","journal-title":"Clin Exp Dermatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1840065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:07:07Z","timestamp":1782284827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1840065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":54,"alternative-id":["10.3389\/fmed.2026.1840065"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1840065","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"1840065"}}